ID   SAC2_HUMAN              Reviewed;        1132 AA.
AC   Q9Y2H2; B3KRF1; D3DRD1; Q2T9J4; Q5W135; Q5W136; Q6NVY2; Q86U97;
AC   Q9H3D9; Q9NT51;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 3.
DT   12-APR-2017, entry version 120.
DE   RecName: Full=Phosphatidylinositide phosphatase SAC2 {ECO:0000305};
DE            EC=3.1.3.25 {ECO:0000269|PubMed:25869668, ECO:0000269|PubMed:25869669};
DE   AltName: Full=Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};
DE   AltName: Full=Sac domain-containing inositol phosphatase 2;
DE   AltName: Full=Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};
DE            Short=hSAC2;
GN   Name=INPP5F {ECO:0000312|HGNC:HGNC:17054}; Synonyms=KIAA0966, SAC2;
GN   ORFNames=MSTP007, MSTP047;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND CAUTION.
RX   PubMed=11274189; DOI=10.1074/jbc.M101579200;
RA   Minagawa T., Ijuin T., Mochizuki Y., Takenawa T.;
RT   "Identification and characterization of a sac domain-containing
RT   phosphoinositide 5-phosphatase.";
RL   J. Biol. Chem. 276:22011-22015(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-997.
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT ASP-997.
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 274-1132 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 956-1132 (ISOFORM 1).
RC   TISSUE=Aorta;
RA   Liu B., Liu Y.Q., Wang X.Y., Zhao B., Sheng H., Zhao X.W., Liu S.,
RA   Xu Y.Y., Ye J., Song L., Gao Y., Zhang C.L., Zhang J., Wei Y.J.,
RA   Cao H.Q., Zhao Y., Liu L.S., Ding J.F., Gao R.L., Wu Q.Y., Qiang B.Q.,
RA   Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION.
RX   PubMed=17322895; DOI=10.1038/nm1552;
RA   Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., Floss T.,
RA   Goettlicher M., Noppinger P.R., Wurst W., Ferrari V.A., Abrams C.S.,
RA   Gruber P.J., Epstein J.A.;
RT   "Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3
RT   beta activity.";
RL   Nat. Med. 13:324-331(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-907 AND SER-1103, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH STAT3.
RX   PubMed=25476455; DOI=10.1038/srep07330;
RA   Kim H.S., Li A., Ahn S., Song H., Zhang W.;
RT   "Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3
RT   activity and suppresses gliomas tumorigenicity.";
RL   Sci. Rep. 4:7330-7330(2014).
RN   [16]
RP   INTERACTION WITH INPP4A; INPP5B AND OCRL.
RX   PubMed=25869668; DOI=10.1083/jcb.201409064;
RA   Nakatsu F., Messa M., Nandez R., Czapla H., Zou Y., Strittmatter S.M.,
RA   De Camilli P.;
RT   "Sac2/INPP5F is an inositol 4-phosphatase that functions in the
RT   endocytic pathway.";
RL   J. Cell Biol. 209:85-95(2015).
RN   [17]
RP   TISSUE SPECIFICITY.
RX   PubMed=26203138; DOI=10.1523/JNEUROSCI.1718-15.2015;
RA   Zou Y., Stagi M., Wang X., Yigitkanli K., Siegel C.S., Nakatsu F.,
RA   Cafferty W.B., Strittmatter S.M.;
RT   "Gene-silencing screen for mammalian axon regeneration identifies
RT   Inpp5f (Sac2) as an endogenous suppressor of repair after spinal cord
RT   injury.";
RL   J. Neurosci. 35:10429-10439(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.62 ANGSTROMS) OF 593-760, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-458.
RX   PubMed=25869669; DOI=10.1083/jcb.201408027;
RA   Hsu F., Hu F., Mao Y.;
RT   "Spatiotemporal control of phosphatidylinositol 4-phosphate by Sac2
RT   regulates endocytic recycling.";
RL   J. Cell Biol. 209:97-110(2015).
CC   -!- FUNCTION: Inositol 4-phosphatase which mainly acts on
CC       phosphatidylinositol 4-phosphate. May be functionally linked to
CC       OCRL, which converts phosphatidylinositol 4,5-bisphosphate to
CC       phosphatidylinositol, for a sequential dephosphorylation of
CC       phosphatidylinositol 4,5-bisphosphate at the 5 and 4 position of
CC       inositol, thus playing an important role in the endocytic
CC       recycling (PubMed:25869669). Regulator of TF:TFRC and integrins
CC       recycling pathway, is also involved in cell migration mechanisms
CC       (PubMed:25869669). Modulates AKT/GSK3B pathway by decreasing AKT
CC       and GSK3B phosphorylation (PubMed:17322895). Negatively regulates
CC       STAT3 signaling pathway through inhibition of STAT3
CC       phosphorylation and translocation to the nucleus
CC       (PubMed:25476455). Functionally important modulator of cardiac
CC       myocyte size and of the cardiac response to stress (By
CC       similarity). May play a role as negative regulator of axon
CC       regeneration after central nervous system injuries (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CDA1,
CC       ECO:0000269|PubMed:17322895, ECO:0000269|PubMed:25476455,
CC       ECO:0000269|PubMed:25869669}.
CC   -!- CATALYTIC ACTIVITY: Myo-inositol phosphate + H(2)O = myo-inositol
CC       + phosphate. {ECO:0000269|PubMed:25869668,
CC       ECO:0000269|PubMed:25869669}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=14.3 uM for PtdIns(4,5)P2 (at pH 6.0)
CC         {ECO:0000269|PubMed:11274189};
CC   -!- SUBUNIT: Homodimer (PubMed:25869669). Interacts with OCRL and
CC       RAB5A (PubMed:25869668). Interacts with INPP5B and INPP4A
CC       (PubMed:25869668). Interacts with STAT3; the interaction is
CC       independent of STAT3 'TYR-705' phosphorylation status
CC       (PubMed:25476455). {ECO:0000250|UniProtKB:Q8CDA1,
CC       ECO:0000269|PubMed:25476455, ECO:0000269|PubMed:25869668,
CC       ECO:0000269|PubMed:25869669}.
CC   -!- SUBCELLULAR LOCATION: Membrane, clathrin-coated pit
CC       {ECO:0000269|PubMed:25869669}. Early endosome
CC       {ECO:0000269|PubMed:25869669}. Recycling endosome
CC       {ECO:0000269|PubMed:25869669}. Note=Also found on macropinosomes.
CC       {ECO:0000250|UniProtKB:Q8CDA1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y2H2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2H2-2; Sequence=VSP_033268, VSP_033269;
CC       Name=3;
CC         IsoId=Q9Y2H2-3; Sequence=VSP_033266, VSP_033267;
CC       Name=4;
CC         IsoId=Q9Y2H2-4; Sequence=VSP_046366, VSP_046367;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous (PubMed:11274189). Highly expressed
CC       in brain (PubMed:26203138). {ECO:0000269|PubMed:11274189,
CC       ECO:0000269|PubMed:26203138}.
CC   -!- CAUTION: INPP5F has been initially described as an inositol
CC       polyphosphate 5-phosphatase. {ECO:0000269|PubMed:11274189}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76810.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023183; BAA76810.2; ALT_INIT; mRNA.
DR   EMBL; AK091448; BAG52363.1; -; mRNA.
DR   EMBL; AC027672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133461; CAH72974.1; -; Genomic_DNA.
DR   EMBL; AL158014; CAH72974.1; JOINED; Genomic_DNA.
DR   EMBL; AL158014; CAI16957.1; -; Genomic_DNA.
DR   EMBL; AL133461; CAI16957.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49379.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49380.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49381.1; -; Genomic_DNA.
DR   EMBL; BC052367; AAH52367.1; -; mRNA.
DR   EMBL; BC067820; AAH67820.1; -; mRNA.
DR   EMBL; BC082755; AAH82755.1; -; mRNA.
DR   EMBL; BC111493; AAI11494.1; -; mRNA.
DR   EMBL; AL137528; CAB70792.1; -; mRNA.
DR   EMBL; AF113227; AAG39298.1; -; mRNA.
DR   EMBL; AF109361; AAQ13509.1; -; mRNA.
DR   CCDS; CCDS58098.1; -. [Q9Y2H2-4]
DR   CCDS; CCDS7616.1; -. [Q9Y2H2-1]
DR   CCDS; CCDS81513.1; -. [Q9Y2H2-3]
DR   PIR; T46372; T46372.
DR   RefSeq; NP_001230123.1; NM_001243194.1. [Q9Y2H2-4]
DR   RefSeq; NP_001230124.1; NM_001243195.1. [Q9Y2H2-3]
DR   RefSeq; NP_055752.1; NM_014937.3. [Q9Y2H2-1]
DR   UniGene; Hs.369755; -.
DR   PDB; 4XUU; X-ray; 2.62 A; A/B/C/D=593-760.
DR   PDBsum; 4XUU; -.
DR   ProteinModelPortal; Q9Y2H2; -.
DR   SMR; Q9Y2H2; -.
DR   BioGrid; 116543; 1.
DR   IntAct; Q9Y2H2; 1.
DR   STRING; 9606.ENSP00000354519; -.
DR   DEPOD; Q9Y2H2; -.
DR   iPTMnet; Q9Y2H2; -.
DR   PhosphoSitePlus; Q9Y2H2; -.
DR   SwissPalm; Q9Y2H2; -.
DR   BioMuta; INPP5F; -.
DR   DMDM; 187611527; -.
DR   EPD; Q9Y2H2; -.
DR   PaxDb; Q9Y2H2; -.
DR   PeptideAtlas; Q9Y2H2; -.
DR   PRIDE; Q9Y2H2; -.
DR   Ensembl; ENST00000361976; ENSP00000354519; ENSG00000198825. [Q9Y2H2-1]
DR   Ensembl; ENST00000369080; ENSP00000358076; ENSG00000198825. [Q9Y2H2-4]
DR   Ensembl; ENST00000369081; ENSP00000489864; ENSG00000198825. [Q9Y2H2-3]
DR   GeneID; 22876; -.
DR   KEGG; hsa:22876; -.
DR   UCSC; uc001leo.4; human. [Q9Y2H2-1]
DR   CTD; 22876; -.
DR   DisGeNET; 22876; -.
DR   GeneCards; INPP5F; -.
DR   HGNC; HGNC:17054; INPP5F.
DR   MIM; 609389; gene.
DR   neXtProt; NX_Q9Y2H2; -.
DR   OpenTargets; ENSG00000198825; -.
DR   PharmGKB; PA134927878; -.
DR   eggNOG; KOG1890; Eukaryota.
DR   eggNOG; COG5329; LUCA.
DR   GeneTree; ENSGT00530000063393; -.
DR   HOGENOM; HOG000139946; -.
DR   HOVERGEN; HBG095361; -.
DR   InParanoid; Q9Y2H2; -.
DR   OMA; ENTGVMD; -.
DR   OrthoDB; EOG091G059J; -.
DR   PhylomeDB; Q9Y2H2; -.
DR   TreeFam; TF313543; -.
DR   BioCyc; MetaCyc:HS12255-MONOMER; -.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   ChiTaRS; INPP5F; human.
DR   GenomeRNAi; 22876; -.
DR   PRO; PR:Q9Y2H2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000198825; -.
DR   CleanEx; HS_INPP5F; -.
DR   ExpressionAtlas; Q9Y2H2; baseline and differential.
DR   Genevisible; Q9Y2H2; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0008934; F:inositol monophosphate 1-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052832; F:inositol monophosphate 3-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052833; F:inositol monophosphate 4-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0034596; F:phosphatidylinositol phosphate 4-phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034595; F:phosphatidylinositol phosphate 5-phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; ISS:UniProtKB.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISS:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:BHF-UCL.
DR   GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0031161; P:phosphatidylinositol catabolic process; ISS:UniProtKB.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2000145; P:regulation of cell motility; IMP:UniProtKB.
DR   GO; GO:2001135; P:regulation of endocytic recycling; IMP:UniProtKB.
DR   GO; GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl.
DR   InterPro; IPR034753; hSac2.
DR   InterPro; IPR022158; Inositol_phosphatase.
DR   InterPro; IPR002013; SAC_dom.
DR   Pfam; PF12456; hSac2; 1.
DR   Pfam; PF02383; Syja_N; 1.
DR   PROSITE; PS51791; HSAC2; 1.
DR   PROSITE; PS50275; SAC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coated pit; Complete proteome;
KW   Endosome; Hydrolase; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1   1132       Phosphatidylinositide phosphatase SAC2.
FT                                /FTId=PRO_0000331621.
FT   DOMAIN      167    518       SAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00183}.
FT   DOMAIN      593    760       hSac2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01127}.
FT   MOD_RES     827    827       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CDA1}.
FT   MOD_RES     830    830       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CDA1}.
FT   MOD_RES     878    878       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CDA1}.
FT   MOD_RES     881    881       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CDA1}.
FT   MOD_RES     907    907       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     910    910       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CDA1}.
FT   MOD_RES    1103   1103       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     19       MELFQAKDHYILQQGERAL -> MCHDVIFMAWLKQQFSEC
FT                                T (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046366.
FT   VAR_SEQ      20    629       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046367.
FT   VAR_SEQ     206    219       DDRFFWNKYMIQDL -> PLTARRAGFALGKK (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033266.
FT   VAR_SEQ     220   1132       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033267.
FT   VAR_SEQ     373    375       VII -> QQK (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033268.
FT   VAR_SEQ     376   1132       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_033269.
FT   VARIANT     453    453       I -> V (in dbSNP:rs3736822).
FT                                /FTId=VAR_042907.
FT   VARIANT     997    997       N -> D (in dbSNP:rs3188055).
FT                                {ECO:0000269|PubMed:10231032,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_042908.
FT   MUTAGEN     458    458       C->S: Loss of inositol 4-phosphatase
FT                                activity. Alters TFRC distribution and
FT                                delays TF recycling.
FT                                {ECO:0000269|PubMed:25869669}.
FT   CONFLICT    386    386       I -> V (in Ref. 6; AAI11494).
FT                                {ECO:0000305}.
FT   CONFLICT    654    654       Y -> N (in Ref. 3; BAG52363).
FT                                {ECO:0000305}.
FT   CONFLICT   1008   1008       P -> L (in Ref. 3; BAG52363).
FT                                {ECO:0000305}.
FT   CONFLICT   1019   1019       S -> P (in Ref. 3; BAG52363).
FT                                {ECO:0000305}.
FT   HELIX       595    610       {ECO:0000244|PDB:4XUU}.
FT   STRAND      617    625       {ECO:0000244|PDB:4XUU}.
FT   STRAND      639    654       {ECO:0000244|PDB:4XUU}.
FT   STRAND      656    668       {ECO:0000244|PDB:4XUU}.
FT   HELIX       669    671       {ECO:0000244|PDB:4XUU}.
FT   STRAND      672    679       {ECO:0000244|PDB:4XUU}.
FT   STRAND      683    685       {ECO:0000244|PDB:4XUU}.
FT   STRAND      689    698       {ECO:0000244|PDB:4XUU}.
FT   STRAND      701    710       {ECO:0000244|PDB:4XUU}.
FT   HELIX       720    736       {ECO:0000244|PDB:4XUU}.
FT   STRAND      743    746       {ECO:0000244|PDB:4XUU}.
SQ   SEQUENCE   1132 AA;  128407 MW;  853719FC0AD455CD CRC64;
     MELFQAKDHY ILQQGERALW CSRRDGGLQL RPATDLLLAW NPICLGLVEG VIGKIQLHSD
     LPWWLILIRQ KALVGKLPGD HEVCKVTKIA VLSLSEMEPQ DLELELCKKH HFGINKPEKI
     IPSPDDSKFL LKTFTHIKSN VSAPNKKKVK ESKEKEKLER RLLEELLKMF MDSESFYYSL
     TYDLTNSVQR QSTGERDGRP LWQKVDDRFF WNKYMIQDLT EIGTPDVDFW IIPMIQGFVQ
     IEELVVNYTE SSDDEKSSPE TPPQESTCVD DIHPRFLVAL ISRRSRHRAG MRYKRRGVDK
     NGNVANYVET EQLIHVHNHT LSFVQTRGSV PVFWSQVGYR YNPRPRLDRS EKETVAYFCA
     HFEEQLNIYK KQVIINLVDQ AGREKIIGDA YLKQVLLFNN SHLTYVSFDF HEHCRGMKFE
     NVQTLTDAIY DIILDMKWCW VDEAGVICKQ EGIFRVNCMD CLDRTNVVQA AIARVVMEQQ
     LKKLGVMPPE QPLPVKCNRI YQIMWANNGD SISRQYAGTA ALKGDFTRTG ERKLAGVMKD
     GVNSANRYYL NRFKDAYRQA VIDLMQGIPV TEDLYSIFTK EKEHEALHKE NQRSHQELIS
     QLLQSYMKLL LPDDEKFHGG WALIDCDPSL IDATHRDVDV LLLLSNSAYY VAYYDDEVDK
     VNQYQRLSLE NLEKIEIGPE PTLFGKPKFS CMRLHYRYKE ASGYFHTLRA VMRNPEEDGK
     DTLQCIAEML QITKQAMGSD LPIIEKKLER KSSKPHEDII GIRSQNQGSL AQGKNFLMSK
     FSSLNQKVKQ TKSNVNIGNL RKLGNFTKPE MKVNFLKPNL KVNLWKSDSS LETMENTGVM
     DKVQAESDGD MSSDNDSYHS DEFLTNSKSD EDRQLANSLE SVGPIDYVLP SCGIIASAPR
     LGSRSQSLSS TDSSVHAPSE ITVAHGSGLG KGQESPLKKS PSAGDVHILT GFAKPMDIYC
     HRFVQDAQNK VTHLSETRSV SQQASQERNQ MTNQVSNETQ SESTEQTPSR PSQLDVSLSA
     TGPQFLSVEP AHSVASQKTP TSASSMLELE TGLHVTPSPS ESSSSRAVSP FAKIRSSMVQ
     VASITQAGLT HGINFAVSKV QKSPPEPEII NQVQQNELKK MFIQCQTRII QI
//
